Healthcare & Life Sciences
Trishula Therapeutics
United Stateswww.trishulatx.com
Trishula Therapeutics is a Healthcare & Life Sciences startup based in the United States, most recent round Series A, 2 tracked investors.
activeseries-a
series-a
Stage
2021
Founded
2
Investors
About Trishula Therapeutics
Based in the United States, Trishula Therapeutics is a startup founded in 2021. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.
Trishula Therapeutics is a clinical-stage biotech company focused on developing TTX-030, a first-in-class anti-CD39 antibody for advanced cancers, aiming to improve treatment outcomes by targeting immune evasion mechanisms in tumors.
Explore Trishula Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.